Back to top
more

Chemours (CC)

(Delayed Data from NYSE)

$27.69 USD

27.69
1,075,019

+0.37 (1.35%)

Updated Apr 29, 2024 04:00 PM ET

After-Market: $27.69 0.00 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

5-Strong Sell of 5         5

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value A Growth F Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 38% (95 out of 252)

Industry: Chemical - Diversified

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Zacks Industry Outlook Highlights Albemarle, The Chemours, Univar Solutions and Innospec

by Zacks Equity Research

Albemarle, The Chemours, Univar Solutions and Innospec have been highlighted in this Industry Outlook article.

Anindya Barman headshot

4 Stocks to Buy From the Prospering Diversified Chemical Industry

by Anindya Barman

A recovery in demand in major end markets should enable the Zacks Chemicals Diversified industry to thrive. ALB, CC, UNVR and IOSP are set to gain from favorable industry fundamentals and strategic actions to counter cost inflation.

Chemours (CC) Stock Moves -0.38%: What You Should Know

by Zacks Equity Research

Chemours (CC) closed the most recent trading day at $33.81, moving -0.38% from the previous trading session.

Why You Should Add Ashland (ASH) Stock to Your Portfolio

by Zacks Equity Research

Ashland (ASH) gains on strong demand in its consumer end markets and its pricing actions to counter inflation.

Ingevity (NGVT) Gains on Demand Strength and Growth Actions

by Zacks Equity Research

Ingevity (NGVT) benefits from strength in its engineered polymers and industrial specialties businesses and actions to drive growth.

Anindya Barman headshot

5 Top-Notch Dividend Plays in the Diversified Chemical Industry

by Anindya Barman

Against the current volatile macroeconomic backdrop, it would be prudent to add some top-quality dividend-paying chemical stocks in your portfolio. CC, CBT, HUN, LYB and TROX fit the bill.

Is Chemours (CC) Outperforming Other Basic Materials Stocks This Year?

by Zacks Equity Research

Here is how Chemours (CC) and SQM (SQM) have performed compared to their sector so far this year.

Is Chemours (CC) Stock Undervalued Right Now?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

CC vs. PPG: Which Stock Should Value Investors Buy Now?

by Zacks Equity Research

CC vs. PPG: Which Stock Is the Better Value Option?

Chemours (CC) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now

by Zacks Equity Research

After losing some value lately, a hammer chart pattern has been formed for Chemours (CC), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.

Harmony's (HMY) Earnings Down, Revenues Increase Y/Y in FY22

by Zacks Equity Research

Harmony (HMY) benefits from higher year over year average gold prices despite a decline in production in fiscal 2022.

CF Industries (CF) Shares Up 11% in 3 Months: Here's Why

by Zacks Equity Research

CF Industries (CF) gains on higher average selling prices on lower global supply availability and strong demand.

Ashland (ASH) Shares Up 17% in 6 Months: What's Driving It?

by Zacks Equity Research

Ashland (ASH) benefits from strong demand in its end markets and its pricing actions to counter inflation.

What Makes Albemarle (ALB) Stock a Solid Choice Right Now

by Zacks Equity Research

Albemarle (ALB) gains on higher volumes and prices in its lithium business and actions to boost its global lithium conversion capacity.

Gold Fields (GFI) Reports Higher Revenues and Profits in 1H22

by Zacks Equity Research

Backed by a ramped-up production and a 3% higher gold price, Gold Fields (GFI) delivers a 16% rise in its normalized earnings in the first half of 2022.

Here's Why You Should Invest in Chemours (CC) Stock Now

by Zacks Equity Research

Chemours (CC) gains on strong end-market demand and its cost-reduction and pricing actions.

Reliance Steel (RS) Gains on Demand Strength, Acquisitions

by Zacks Equity Research

Reliance Steel (RS) benefits from strong underlying demand in its major markets, the strength in metals pricing and strategic acquisitions.

Why You Should Add Ingevity (NGVT) Stock to Your Portfolio

by Zacks Equity Research

Ingevity (NGVT) rides on solid demand and higher selling prices in engineered polymers and industrial specialties businesses and its growth actions.

Albemarle (ALB) Shares Pop 50% in 6 Months: What's Driving It?

by Zacks Equity Research

Forecast-topping earnings performance in Q2 and upbeat outlook for 2022 have contributed to the rally in Albemarle's (ALB) shares.

Here's Why Chemours (CC) is a Strong Value Stock

by Zacks Equity Research

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Is Chemours (CC) a Great Value Stock Right Now?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Sociedad Quimica (SQM) Q2 Earnings Lag Estimates, Sales Beat

by Zacks Equity Research

Sociedad Quimica (SQM) benefits from a significant increase in lithium prices in the second quarter.

CC or PPG: Which Is the Better Value Stock Right Now?

by Zacks Equity Research

CC vs. PPG: Which Stock Is the Better Value Option?

Has Chemours (CC) Outpaced Other Basic Materials Stocks This Year?

by Zacks Equity Research

Here is how Chemours (CC) and Ryerson Holding (RYI) have performed compared to their sector so far this year.

Chemours (CC) Stock Up 25% in 6 Months: What's Driving It?

by Zacks Equity Research

Chemours (CC) gains on healthy demand, strong execution and its cost-reduction and pricing actions.